3D Mammography Screening
New 3D Mammography offers a better chance to diagnose breast cancer earlier, at more treatable stages
Women’s Care Florida offers 3D mammography (breast tomosynthesis) for breast cancer screening. Breast tomosynthesis produces a three-dimensional view of the breast tissue that helps radiologists identify and characterize individual breast structures without the confusion of overlapping tissue.
The center’s Selenia® Dimensions® breast tomosynthesis system is made by Hologic, a world leader in digital mammography. The Selenia Dimensions system offers exceptionally sharp breast images, an advanced ergonomic design providing more patient comfort, and the ground-breaking tomosynthesis platform designed to deliver superior screening and diagnostic performance for all breast types. 1 We believe breast tomosynthesis will benefit all screening and diagnostic mammography patients, and is especially valuable for women receiving a baseline screening, those who have dense breast tissue and/or women with a personal history of breast cancer.
Breast cancer screening with tomosynthesis when combined with a conventional 2D mammography has a 40% higher invasive cancer detection rate than conventional 2D mammography alone.2-4 Tomosynthesis technology gives radiologists increased confidence with up to a 40% reduction in recall rates. 4-5
The tomosynthesis screening experience is similar to a traditional mammogram. During a tomosynthesis exam, multiple, low-dose images of the breast are acquired at different angles. These images are then used to produce a series of one-millimeter thick slices that can be viewed as a 3D reconstruction of the breast.
By offering women the latest and more accurate6 technology in mammography, Women’s Care Florida expects to increase the number of area women who will be routinely screened. Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics indicate that one in eight women will develop breast cancer sometime in her lifetime. The stage at which breast cancer is detected influences a woman’s chance of survival. If detected early, the five-year survival rate is 98 percent. 7
Women’s Care Florida is committed to the fight against breast cancer. In offering breast tomosynthesis digital mammography, we provide the latest in imaging technology. If you would like to schedule a mammogram or have questions about this important breast health procedure, please contact your provider.
Before Your Visit
Prior to your first screening, please complete the
Please send the completed form to your provider prior to your scheduled appointment. This will allow us to obtain your previous mammogram records for a comprehensive and more timely evaluation of your past medical history.
- Journal of the American Medical Association (JAMA) study
3-D Mammography Test Appears to Improve Breast Cancer
Watch this informational video to learn more about 3D mammography screening.
2 Skaane P, Bandos A, Gullien R, et al. “Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program.” Radiology. 2013 Apr; 267(1):47-56. Epub 2013 Jan 7.
3 Ciatto S, Houssami N, Bernardi D, et al. “Integration of 3D Digital Mammography with Tomosynthesis for Population Breast-Cancer Screening (STORM): A Prospective Comparison Study” The Lancet Oncology. 2013 Jun;14(7):583-589. Epub 2013 Apr 25.
4 Rose S, Tidwell A, Bujnock L, et al. “Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study.” American Journal of Roentengenology. 2013 Jun; 200(6): 1401-1408. Epub 2013 May 22.
5 Haas B, Kalra V, Geisel, J et al. “Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer Screening.” Radiology. 2013 Jul 30. [Epub ahead of print].
6Zuley M, Bandos A, Ganott M, et al. “Digital Breast Tomosynthesis versus Supplemental Diagnostic Mammographic Views for Evaluation of Noncalcified Breast Lesions.” Radiology. 2013 Jan; 266(1):89-95. Epub 2012 Nov 9.
7 Breast Cancer Facts & Figures 2011, American Cancer Society.